Evidence map›Paper›PMID 11283236›Full record

ArticleThe Journal of physiology2001

Presynaptic function is altered in snake K+-depolarized motor nerve terminals containing compromised mitochondria.

M A Calupca, C Prior, L A Merriam, G M Hendricks, R L Parsons

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Synaptic mitochondrial pathology in Alzheimer's disease.Antioxidants & redox signaling · 2012
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mitochondrial trafficking to synapses in cultured primary cortical neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  8. Modulation of synaptic transmission by the BCL-2 family protein BCL-xL.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

M A CalupcaDepartment of Anatomy and Neurobiology, University of Vermont College of Medicine, Burlington, VT 05405, USA.
C Prior
L A Merriam
G M Hendricks
R L Parsons
University of Vermont · USUniversity of Strathclyde · GB

Funding

TRNSMITTER INTERACTION IN A CARDIAC GANGLIONR01NS023978 · NINDS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 1986 to 2000
$269k
NINDS NIH HHS NS 23978
6 · The paper itself

Abstract

Presynaptic function was investigated at K+-stimulated motor nerve terminals in snake costocutaneous nerve muscle preparations exposed to carbonyl cyanide m-chlorophenylhydrazone (CCCP, 2 M), oligomycin (8 g x ml(-1)) or CCCP and oligomycin together. Miniature endplate currents (MEPCs) were recorded at -150 mV with two-electrode voltage clamp. With all three drug treatments, during stimulation by elevated K+ (35 mM), MEPC frequencies initially increased to values > 350 s(-1), but then declined. The decline occurred more rapidly in preparations treated with CCCP or CCCP and oligomycin together than in those treated with oligomycin alone. Staining with FM1-43 indicated that synaptic vesicle membrane endocytosis occurred at some CCCP- or oligomycin-treated nerve terminals after 120 or 180 min of K+ stimulation, respectively. The addition of glucose to stimulate production of ATP by glycolysis during sustained K+ stimulation attenuated the decline in MEPC frequency and increased the percentage of terminals stained by FM1-43 in preparations exposed to either CCCP or oligomycin. We propose that the decline in K+-stimulated quantal release in preparations treated with CCCP, oligomycin or CCCP and oligomycin together could result from a progressive elevation of intracellular calcium concentration ([Ca2+]i). For oligomycin-treated nerve terminals, a progressive elevation of [Ca2+]i could occur as the cytoplasmic ATP/ADP ratio decreases, causing energy-dependent Ca2+ buffering mechanisms to fail. The decline in MEPC frequency could occur more rapidly in preparations treated with CCCP or CCCP and oligomycin together because mitochondrial Ca2+ buffering and ATP production were both inhibited. Therefore, the proposed sustained elevation of [Ca2+]i could occur more rapidly.

Indexed as

Action PotentialsAdenosine TriphosphateAnimalsCalciumCarbonyl Cyanide m-Chlorophenyl HydrazoneColubridaeEndocytosisEnzyme InhibitorsFluorescent DyesGlucoseMitochondriaMotor EndplateMuscle Fibers, SkeletalMuscle, SkeletalOligomycinsPatch-Clamp TechniquesAdenosine TriphosphateCalciumCarbonyl Cyanide m-Chlorophenyl HydrazoneEnzyme InhibitorsFluorescent DyesFM1 43GlucoseOligomycinsPotassiumPropionatespropionic acidPyridinium CompoundsQuaternary Ammonium CompoundsUncoupling Agents

Identifiers

PMID11283236
PMCPMC2278518
OpenAlexW2063020331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.